| Formulation development of albumin based theragnostic nanoparticles as a potential delivery system for tumor targeting LP Kolluru, SAA Rizvi, M D’Souza, MJ D’Souza Journal of drug targeting 21 (1), 77-86, 2013 | 60 | 2013 |
| Characterization and applications of colloidal systems as versatile drug delivery carriers for parenteral formulations LP Kolluru, P Atre, SAA Rizvi Pharmaceuticals 14 (2), 108, 2021 | 20 | 2021 |
| Development and evaluation of polycaprolactone based docetaxel nanoparticle formulation for targeted breast cancer therapy LP Kolluru, T Chandran, PN Shastri, SAA Rizvi, MJ D’Souza Journal of Nanoparticle Research 22, 1-14, 2020 | 19 | 2020 |
| Design of Experiments: A Valuable “Quality by Design” tool in formulation development LP Kolluru, RP Gala, PN Shastri, R Ubale Nanopart. Vaccine Deliv. Syst 61 (10.1201), 2015 | 8 | 2015 |
| Sterility Assurance of Parenteral Products Major Deficiency for Recall LP Kolluru Journal of Pharmacovigilance 5 (2), 2017 | 6* | 2017 |
| Immune-potentiation of Pneumococcal Capsular Polysaccharide Antigen using Albumin Microparticles et al. D’Souza B, Shastri PN, Hammons G, Kim E, Kolluru LP Journal of Pharmacovigilance 6 (3), 2018 | 4 | 2018 |
| Microparticulate Formulation for a Pneumococcal Capsular Polysaccharide Antigen B D'Souza, PN Shastri, G Hammons, LP Kolluru, NS Mulla, G Rajam Nanoparticulate Vaccine Delivery Systems, 115-127, 2015 | 3 | 2015 |
| Basic Considerations for Container Closure Selection of Parenteral Drug Products LP Kolluru Journal of Pharmaceutical Analytica Acta 8 (5), 2017 | 2 | 2017 |
| Dexmedetomidine injection premix formulation in ready to use (RTU) bags LP Kolluru, Z Guan, S Potdar, R Malhotra, P Aggarwal US Patent 11,160,791, 2021 | | 2021 |
| Formulation Design and Development of Theranostic Nanoparticles for Tumor Targeted Drug Delivery LP Kolluru Mercer University College of Pharmacy, 2014 | | 2014 |
